Stereochemistry and Its Role in Drug Design
Received Date: Aug 01, 2022 / Accepted Date: Aug 31, 2022 / Published Date: Aug 31, 2022
Abstract
When designing small motes to interact with the targets, one should consider stereos electivity. As considerations for exploring structure space evolve, chirality is decreasingly important. List affinity for a chiral medicine can differ for diastereomers and between enantiomers. For the virtual webbing and computational design stage of medicine development, this problem can be compounded by deficient stereo chemical information in structure libraries leading to a" coin toss" as to whether or not the" ideal" chiral structure is present. Creating every stereoisomer for each chiral emulsion in a structure library leads to an exponential increase in the number of structures performing in potentially ungovernable train sizes and webbing times. Thus, only crucial chiral structures, enantiomeric dyads grounded on relative stereochemistry need be included, and lead to a concession between disquisition of chemical space and maintaining manageable libraries.
Citation: Kiran MA (2022) Stereochemistry and Its Role in Drug Design. Clin Pharmacol Biopharm, 11: 282. Doi: 10.4172/2167-065X.1000282
Copyright: © 2022 Kiran MA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 2116
- [From(publication date): 0-2022 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 1877
- PDF downloads: 239